The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

So compounded semaglutide is sold in a vial with a separate syringe ... CEO of the Alliance for Pharmacy Compounding. As ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

Novo Nordisk, the pharmaceutical giant that makes Ozempic and Wegovy, emphasizes there is no generic semaglutide currently ... your medicine from a compounding pharmacy, you may no longer be ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

Compounding pharmacies use active pharmaceutical ingredients – the part of the medication that produces therapeutic effects – ...

The Alliance for Pharmacy Compounding (APC), a trade organisation representing the compounding industry, has claimed that Novo Nordisk is "confusing the fact that the semaglutide molecule is ...

Hundreds of thousands of people across the country are taking Semaglutide or Tirzepatide. Many of those people get their medication through a compounding pharmacy as opposed to getting the brand ...

Novo Nordisk, the pharmaceutical company that currently produces FDA-approved semaglutide products, including Ozempic, does not sell semaglutide for compounding. This has led to concerns over the ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...